Endoscopic full-thickness plication (Plicator) with two serially placed implants improves esophagitis and reduces PPI use and esophageal acid exposure

Background and study aims: Recently, several endoluminal procedures for the treatment of gastroesophageal reflux disease (GERD) have been introduced. Most of these techniques have been abandoned because they lack long-term efficacy or have serious side effects. In a recently published prospective randomized, sham-controlled trial, the Plicator was shown to be effective at controlling reflux symptoms and esophageal acid exposure. In all previous studies, only a single implant was used. The aim of the present pilot study was to determine the safety and efficacy of two serially placed Plicator implants.

Patients and methods: Thirty-seven patients requiring maintenance therapy with proton pump inhibitors (PPIs) were enrolled in this single-center pilot study. All patients received two Plicator implants. Exclusion criteria were hiatus hernia larger than 3 cm, grade IV esophagitis, Barrett’s esophagus, and esophageal motility disorders. The primary study end point was at least 50 % improvement in the GERD Health-Related Quality of Life (HRQL) score. Secondary end points included GERD medication use, esophageal acid exposure, esophagitis grade, and heartburn/regurgitation scores.

Results: Thirty-seven patients underwent endoscopic full-thickness plication using two serially placed Plicator implants. At 6 months after treatment, the proportion of patients achieving at least 50 % improvement in GERD-HRQL score was 68 %. Complete cessation of PPI treatment was achieved in 59 % of patients. In pH studies conducted at 6 months (n = 29), median percentage of time for which pH was below 4 decreased by 36 %, with 28 % of patients experiencing pH normalization. There were no serious adverse events requiring intervention.

Conclusions: Endoscopic full-thickness plication using two serially placed Plicator implants was both safe and effective in reducing esophagitis, GERD symptoms, medication use, and esophageal acid exposure.

References

• 1 Vakil N, van Zanten S V, Jones R. et al . The Montreal definition and classification of gastroesophageal reflux disease: a global evidence-based consensus.  Am J Gastroenterol. 2006;  101 1900-1920
• 2 Klinkenberg-Knol E C, Festen H P, Meuwissen S G. Pharmacological management of gastro-oesophageal reflux disease.  Drugs. 1995;  49 695-710
• 3 Koop H, Schepp W, Hotz J. et al . Consensus conference of the DGVS on gastroesophageal reflux.  Z Gastroenterol. 2005;  43 163-194
• 4 Meining A, Bajbouj M, Schmid R M. et al . Diagnosis and therapy of weakly-acid/non-acidic gastroesophageal reflux disease.  Dtsch Med Wochenschr. 2005;  130 2266-2269
• 5 Schilling D, Riemann J F. Evidence based conservative therapy of gastroesophageal reflux.  Internist. 2003;  44 21-27
• 6 Corley D A, Katz P, Wolfe M M. et al . Improvement of gastroesophageal reflux symptoms after radiofrequency energy: a randomized, sham-controlled trial.  Gastroenterology. 2003;  125 668-676
• 7 Deviere J, Costamagna G, Schumacher B. et al . Nonresorbable copolymer implantation for gastroesophageal reflux disease: a randomized sham-controlled multicenter trial.  Gastroenterology. 2005;  128 532-540
• 8 Hogan W J. Clinical trials evaluating endoscopic GERD treatments: is it time for a moratorium on the clinical use of these procedures?.  Am J Gastroenterol. 2006;  101 437-439
• 9 Zhi X T, Kavic S M, Park A E. Management of gastroesophageal reflux disease: medications, surgery, or endoscopic therapy?.  J Long Term Eff Med Implants. 2005;  15 375-388
• 10 Schilling D, Kiesslich R, Riemann J F. et al . Endoluminal therapy of GERD with a new endoscopic suturing device.  Gastrointest Endosc. 2005;  62 37-43
• 11 Pleskow D, Rothstein R, Lembo A. et al . Endoscopic full-thickness plication for the treatment of GERD: 12-month follow-up for the North American open-label trial.  Gastrointest Endosc. 2005;  61 643-649
• 12 Pleskow D, Rothstein R, Lo S. et al . Endoscopic full-thickness plication for the treatment of GERD: a multicenter trial.  Gastrointest Endosc. 2004;  59 163-171
• 13 Rothstein , R , Filipi C, Lembo A. et al . Endoscopic full-thickness plication for the treatment of gastroesophageal reflux disease: a randomized, sham-controlled trial.  Gastroenterology. 2006;  131 704-712
• 14 Romagnuolo J. Endoscopic “antireflux” procedures: not yet ready for prime time.  Can J Gastroenterol. 2004;  18 573-577
• 15 Shaheen N J. The rise and fall (and rise?) of endoscopic anti-reflux procedures.  Gastroenterology. 2006;  131 952-954
• 16 Triadafilopoulos G. Endotherapy for GERD: angels and demons.  Gastrointest Endosc. 2005;  61 668-670
• 17 Dent J, Brun J, Fendrick A M. et al . An evidence-based appraisal of reflux disease management: the Genval workshop report.  Gut. 1999;  44 1-16
• 18 Fuchs K H, Feussner H. Laparoscopic fundoplication. Indications and results.  Internist. 2003;  44 36-42